
     RDKit          2D

 17 16  0  0  0  0  0  0  0  0999 V2000
    0.7145    0.9281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -0.3094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.1344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    0.9281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  2  1  1
  4  5  1  0
  6  4  1  0
  6  7  1  1
  6  8  1  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 15  1  0
  8 16  1  0
  8 17  1  0
M  END
>  <ALOGPS_LOGP>  (1) 
-3.01

>  <ALOGPS_LOGS>  (1) 
0.60

>  <ALOGPS_SOLUBILITY>  (1) 
4.77e+02 g/l

>  <DATABASE_ID>  (1) 
DB00156

>  <DATABASE_NAME>  (1) 
drugbank

>  <DRUGBANK_ID>  (1) 
DB00156

>  <DRUG_GROUPS>  (1) 
approved; nutraceutical

>  <EXACT_MASS>  (1) 
119.058243159

>  <FORMULA>  (1) 
C4H9NO3

>  <GENERIC_NAME>  (1) 
L-Threonine

>  <INCHI_IDENTIFIER>  (1) 
InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1

>  <INCHI_KEY>  (1) 
AYFVYJQAPQTCCC-GBXIJSLDSA-N

>  <JCHEM_ACCEPTOR_COUNT>  (1) 
4

>  <JCHEM_AVERAGE_POLARIZABILITY>  (1) 
11.078258022254149

>  <JCHEM_BIOAVAILABILITY>  (1) 
1

>  <JCHEM_DONOR_COUNT>  (1) 
3

>  <JCHEM_FORMAL_CHARGE>  (1) 
0

>  <JCHEM_GHOSE_FILTER>  (1) 
0

>  <JCHEM_IUPAC>  (1) 
(2S,3R)-2-amino-3-hydroxybutanoic acid

>  <JCHEM_LOGP>  (1) 
-3.4709635238772347

>  <JCHEM_MDDR_LIKE_RULE>  (1) 
0

>  <JCHEM_NUMBER_OF_RINGS>  (1) 
0

>  <JCHEM_PHYSIOLOGICAL_CHARGE>  (1) 
0

>  <JCHEM_PKA>  (1) 
14.953369305664726

>  <JCHEM_PKA_STRONGEST_ACIDIC>  (1) 
2.207432028688761

>  <JCHEM_PKA_STRONGEST_BASIC>  (1) 
9.002504827404067

>  <JCHEM_POLAR_SURFACE_AREA>  (1) 
83.55

>  <JCHEM_REFRACTIVITY>  (1) 
26.4598

>  <JCHEM_ROTATABLE_BOND_COUNT>  (1) 
2

>  <JCHEM_RULE_OF_FIVE>  (1) 
1

>  <JCHEM_TRADITIONAL_IUPAC>  (1) 
L-threonine

>  <JCHEM_VEBER_RULE>  (1) 
0

>  <MOLECULAR_WEIGHT>  (1) 
119.1192

>  <PRODUCTS>  (1) 
2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose; 2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix; 2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix; 2.5%travasol Amino Acid InJ.W.eleC.W.25%dex; 2.75% Travas. Amino Acid InJ.W.elecw.25%dex; 2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix; 2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix; 2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.; 4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix; 4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose; 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose; 4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix; 4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose; 4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix; 4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose; 4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose; 4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose; 4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix; 4.25%trav. Amino Acid InJ.W.O.elect.5%dext.; 4.25%travasol Amino Acid InJ.W.elecw.5%dex.; 5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose; 5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose; 5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose; Aminoderm Poudre; Aminosyn; Aminosyn 10%; Aminosyn 10% W Electrolytes; Aminosyn 3.5% M; Aminosyn 5%; Aminosyn 7%; Aminosyn 8.5%; Aminosyn 8.5% Injection With Electrolytes; Aminosyn II; Aminosyn II 10%; Aminosyn II 10% With Electrolytes; Aminosyn II 15%; Aminosyn II 5% Inj; Aminosyn II 7% Injection; Aminosyn II 7% M In 10% Dextrose(dual Chamber); Aminosyn II 7% With 10% Dextrose; Aminosyn II 7% With 50% Dextrose; Aminosyn II 8.5% Injection; Aminosyn II 8.5% M In 20% Dextrose (dual Chamber); Aminosyn II 8.5% With 50% Dextrose; Aminosyn II In Dextrose Injection; Aminosyn II with Electrolytes; Aminosyn RF; Aminosyn RF Injection; Aminosyn Sulfite Free; Aminosyn-PF; Aminosyn-PF 10%; Aminosyn-PF 7%; Cicatrin Powder; Clinimix; Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec; Clinimix E; Clinisol; FreAmine HBC; FreAmine III; HepatAmine; NephrAmine; Novamine; Olimel 3.3% E; Olimel 4.4%; Olimel 4.4% E; Olimel 5.7%; Olimel 5.7% E; Periolimel 2.5% E; Plenamine; Premasol - sulfite-free (Amino Acid); Primene 10%; Primene 10%-liq IV; ProSol; Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec; Renamin (amino Acids) Injection; Travasol; Travasol Amino Acid Inj 5.5%; Travasol Amino Acid Inj 8.5%; Travasol E; Travasol Inj Without Electrolytes 5.5%; TrophAmine; Vamin 18 Electrolyte-free; Vamin N

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
NUTR00057

>  <SMILES>  (1) 
C[C@@H](O)[C@H](N)C(O)=O

>  <SYNONYMS>  (1) 
(2S,3R)-(-)-Threonine; (2S)-threonine; 2-Amino-3-hydroxybutyric acid; L-(-)-Threonine; L-2-Amino-3-hydroxybutyric acid; L-alpha-amino-beta-hydroxybutyric acid; L-Threonin; L-α-amino-β-hydroxybutyric acid; Thr; Threonine

$$$$
